Director, Pancreatic Disease Center in Miami Cancer Institute
Gastro Health & Miami Cancer Institute
Miami, FL, United States
Andres Gelrud, MD, MMSc, is a clinical pancreatologist who provides care for patients with acute, recurrent acute, and chronic pancreatitis, as well as treatment of complications from pancreatitis. He also has expertise in interventional endoscopy, a minimally invasive procedure used to diagnose and treat problems of the digestive tract, including gastrointestinal cancers. He is an expert in endoscopic retrograde cholangiopancreatography (ERCP) to diagnose and treat diseases of the bile duct and pancreas. He also performs stent placement of the gastrointestinal tract (esophagus, small bowel, bile duct, and colon). Dr. Gelrud frequently performs transgastric pancreatic necrosectomy. Dr. Gelrud has served as the primary site investigator on several studies that examine the reasons why patients develop pancreatitis. He has a particular interest in exploring the relationship between genetics and diseases of the pancreas. In addition to his clinical and research roles, Dr. Gelrud is an active educator and author. He has written more than 100 articles and abstracts in peer-reviewed journals and contributed to numerous English and Spanish language textbooks on digestive diseases. Dr. Gelrud currently serves on the Board of Directors of the National Pancreas Foundation, and works at Gastro Health and Miami Cancer Institute in South Florida.
AbbVie (Individual(s) Involved: Self): Consultant, Speaker's Bureau; Ariel Precision Medicine (Individual(s) Involved: Self): Advisory Committee/Board Member; Pancreas Journal (Individual(s) Involved: Self): Editorial Board; UpToDate (Individual(s) Involved: Self): Author multiple chapters, Royalties